InsiderTrades

Form 4 for ANAB ANAPTYSBIO, INC

Accepted 2024-03-26 00:00:00 ET · period of report 2024-03-22 · accession 0001415889-24-009164 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-03-26 2024-03-22+ ANAB Faga Daniel CEO, Dir S - Sale $22.75 -148.9K 749.1K -17% -$3.39M
2024-03-26 2024-03-26 ANAB Faga Daniel CEO, Dir F - Tax $21.60 -347.4K 401.6K -46% -$7.50M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-22 S D 145,940 $22.78 752,087 D — — (F2) The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.
2 Common Common Stock 2024-03-26 F D 347,441 $21.60 401,646 D — — (F3) Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation. (F2) The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.
3 Common Common Stock 2024-03-25 S D 3,000 $21.42 749,087 D — — (F2) The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.